Dendreon Corp  DNDN
Last PriceDay ChangeVolume
Open PriceDay Range52-Wk Range
Mkt Cap($mil)YieldAvg Volume
 Stock Chart
Price Graph
 Key Stats
Morningstar Style BoxSmall CoreStock TypeDistressed
Market Cap $Mil-- Sales $Mil299
 Company Profile
What Does This Company Do?

Dendreon is a biotechnology firm focused on discovering, developing, and commercializing novel cancer therapies. The company's only marketed product is prostate cancer treatment Provenge, the first active cellular immunotherapy for cancer to hit the market. Dendreon also has other oncology immunotherapies and small-molecule drug candidates in preclinical and early clinical development.

Address1301 2nd Avenue
 Seattle, WA, 98101
Phone1 206 256-4545
Direct InvestmentNo
Dividend ReinvestmentNo
All quote data supplied by Morningstar Real-Time Data. Quotes for Nasdaq, NYSE and securities are delayed 20 minutes. © Copyright 2010 Morningstar, Inc.
Show Data Definitions
Become a Morningstar Premium Member. Enjoy our analyst picks and buy-sell opinions on 3,800 stocks, funds and ETFs. Learn more.

© Copyright 2015 Morningstar, Inc. All rights reserved. Morningstar, the Morningstar logo,, Morningstar Tools are either trademark or service marks of Morningstar, Inc.
Past performance is no guarantee of future results.
Returns will vary and shares may be worth more or less than their original cost when sold.